Angelica D'Aiello, MD(@DAielloMD) 's Twitter Profileg
Angelica D'Aiello, MD

@DAielloMD

Chief Hematology & Oncology Fellow @MontefioreNYC @EinsteinMed | Interests in Precision Oncology, Thoracic, Cancer Disparities | Marathoner | #lcsm

ID:1299838125875884032

linkhttps://scholar.google.com/citations?user=xk5S8uUAAAAJ&hl=en calendar_today29-08-2020 22:36:46

67 Tweets

254 Followers

398 Following

Balazs Halmos(@DrSteveMartin) 's Twitter Profile Photo

Great work using machine learning by our Montefiore Health System Rad Onc group (they are certainly publishing like a machine!) on how wearable devices can help optimize patient management
Nitin Ohri Albert Einstein College of Medicine - Official

account_circle
Balazs Halmos(@DrSteveMartin) 's Twitter Profile Photo

🙏 Stephen V Liu, MD -outstanding work by Montefiore Health System chief hem/onc fellow Angelica D'Aiello, MD!
Complex/rapidly evolving topic- maybe some of u will want to read our review covering
☑️biology
☑️key trials
☑️biomarkers
☑️case challenges
before your next busy clinic- like neoadjuvantly?😉

🙏 @StephenVLiu -outstanding work by @MontefioreNYC chief hem/onc fellow @DAielloMD! Complex/rapidly evolving topic- maybe some of u will want to read our review covering ☑️biology ☑️key trials ☑️biomarkers ☑️case challenges before your next busy clinic- like neoadjuvantly?😉
account_circle
Ece Cali Daylan, MD, PhD(@ececalidaylan) 's Twitter Profile Photo

New publication alert 🚨 Our latest study delves into the clinicopathologic characteristics of HIV associated lung cancer 🫁🔬🦠 we investigate PD-L1 and tumor-infiltrating lymphocytes in a subset of our cohort, unveiling intriguing findings. Don’t miss out on this read! 📖

account_circle
Brendon Stiles(@BrendonStilesMD) 's Twitter Profile Photo

Congrats to Nitin Ohri Balazs Halmos & collaborators on this ground breaking trial in Journal of Clinical Oncology! Great work from Albert Einstein College of Medicine - Official Montefiore Health System! The SPRINT trial. With all of our amazing progress in lung cancer treatment, shouldn't radioimmunotherapy be 'personalized' too?

Congrats to @NitinOhri3 @DrSteveMartin & collaborators on this ground breaking trial in @JCO_ASCO! Great work from @EinsteinMed @MontefioreNYC! The SPRINT trial. With all of our amazing progress in lung cancer treatment, shouldn't radioimmunotherapy be 'personalized' too? #lcsm
account_circle
Balazs Halmos(@DrSteveMartin) 's Twitter Profile Photo

Our Montefiore Health System Albert Einstein College of Medicine - Official thoracic MDT= multi-disc/mega-diverse team from
➡️all 5 boroughs of NYC
➡️across the US from dairy farms of VA to potato chips of Saratoga Springs
➡️all over the 🌍from 🇯🇵🇮🇳🇭🇺🇺🇾🇭🇳🇯🇲🇰🇷etc to do one thing- our best as a team for each of our patients!

Our @MontefioreNYC @EinsteinMed thoracic MDT= multi-disc/mega-diverse team from ➡️all 5 boroughs of NYC ➡️across the US from dairy farms of VA to potato chips of Saratoga Springs ➡️all over the 🌍from 🇯🇵🇮🇳🇭🇺🇺🇾🇭🇳🇯🇲🇰🇷etc to do one thing- our best as a team for each of our patients!
account_circle
Jarushka Naidoo(@DrJNaidoo) 's Twitter Profile Photo

Interesting study explores features of tumors that recur post chemoRT+durva for stage III nsclc:

- 135pts, pre-Tx tissue&blood
- ⬇️CD8+ TILs, ⬆️CD73+ assoc w poor durva outcome

An area of clinical need, ?antiCD73 anyone
JTO & JTO CRROncoAlert⁩ jto.org/article/S1556-…

account_circle
Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO(@tomleblancMD) 's Twitter Profile Photo

Hand-foot syndrome is a tough patient experience issue in cancer care. New RCT suggests topical diclofenac markedly reduces incidence/severity of HFS, w/less need to dose-reduce effective chemotherapy! Low cost, high impact meetings.asco.org/abstracts-pres…

account_circle
Angelica D'Aiello, MD(@DAielloMD) 's Twitter Profile Photo

🚨TTF: A new modality for mNSCLC?
🌖Phase III Lunar Study
Lung Ca Oral Abstract
🫁TTF + SOC v SOC for mNSCLC after POD on platinum
⭐️3 mo median OS ⬆️ w TTF + SOC vs SOC
⭐️8 mo median OS ⬆️ w TTF + ICI vs SOC
⚠️~50% unknown PD-L1 TPS
⚠️1L tx used no longer SOC

🚨TTF: A new modality for mNSCLC? 🌖Phase III Lunar Study #ASCO2023 Lung Ca Oral Abstract 🫁TTF + SOC v SOC for mNSCLC after POD on platinum ⭐️3 mo median OS ⬆️ w TTF + SOC vs SOC ⭐️8 mo median OS ⬆️ w TTF + ICI vs SOC ⚠️~50% unknown PD-L1 TPS ⚠️1L tx used no longer SOC
account_circle
Balazs Halmos(@DrSteveMartin) 's Twitter Profile Photo

Monte/Einstein hem/onc-past/present (+future?) at w special cameo appearances by Lakshmi Rajdev Joseph A. Sparano, MD Missak Haigentz!
No need to be an Einstein to see what a special group!

(i was told i ordered the most non-Indian Indian food there is for the group- but it looked good, no?

Monte/Einstein hem/onc-past/present (+future?) at #ASCO23 w special cameo appearances by @luckydoc2 @jsparano @DrHaigentz! No need to be an Einstein to see what a special group! (i was told i ordered the most non-Indian Indian food there is for the group- but it looked good, no?
account_circle